1. Home
  2. LYRA vs RTC Comparison

LYRA vs RTC Comparison

Compare LYRA & RTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LYRA
  • RTC
  • Stock Information
  • Founded
  • LYRA 2005
  • RTC 2003
  • Country
  • LYRA United States
  • RTC China
  • Employees
  • LYRA N/A
  • RTC N/A
  • Industry
  • LYRA Medical/Dental Instruments
  • RTC Specialty Chemicals
  • Sector
  • LYRA Health Care
  • RTC Industrials
  • Exchange
  • LYRA Nasdaq
  • RTC Nasdaq
  • Market Cap
  • LYRA 6.1M
  • RTC 6.1M
  • IPO Year
  • LYRA 2020
  • RTC N/A
  • Fundamental
  • Price
  • LYRA $0.10
  • RTC $0.19
  • Analyst Decision
  • LYRA Hold
  • RTC
  • Analyst Count
  • LYRA 4
  • RTC 0
  • Target Price
  • LYRA $1.25
  • RTC N/A
  • AVG Volume (30 Days)
  • LYRA 1.7M
  • RTC 10.4M
  • Earning Date
  • LYRA 04-29-2025
  • RTC 05-06-2025
  • Dividend Yield
  • LYRA N/A
  • RTC N/A
  • EPS Growth
  • LYRA N/A
  • RTC N/A
  • EPS
  • LYRA N/A
  • RTC N/A
  • Revenue
  • LYRA $1,534,000.00
  • RTC $54,533,127.00
  • Revenue This Year
  • LYRA N/A
  • RTC N/A
  • Revenue Next Year
  • LYRA $237.15
  • RTC N/A
  • P/E Ratio
  • LYRA N/A
  • RTC N/A
  • Revenue Growth
  • LYRA N/A
  • RTC N/A
  • 52 Week Low
  • LYRA $0.08
  • RTC $0.16
  • 52 Week High
  • LYRA $5.65
  • RTC $9.69
  • Technical
  • Relative Strength Index (RSI)
  • LYRA 38.11
  • RTC 38.01
  • Support Level
  • LYRA $0.08
  • RTC $0.18
  • Resistance Level
  • LYRA $0.10
  • RTC $0.49
  • Average True Range (ATR)
  • LYRA 0.02
  • RTC 0.05
  • MACD
  • LYRA 0.00
  • RTC 0.02
  • Stochastic Oscillator
  • LYRA 41.71
  • RTC 7.73

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

About RTC Baijiayun Group Ltd.

Baijiayun Group Ltd is a ToB video cloud technology service provider that solves various pain points and needs in the field of video technology applications for enterprises. The group supplies energy for the digital development of enterprises through audio and video technology. The firm provides video technology solutions to enterprises and government agencies in various fields such as automobiles, finance, education, and medical care. Baijiayun has created three categories of product services namely video SaaS/PaaS business, video cloud products and software, and video system solutions. It has set up multiple R&D centers, branches, and offices across the country, enabling video technology to create industrial value and promote the development of the real economy.

Share on Social Networks: